CD9 and prostate carcinoma: Researchers have found that knocking out transmembrane tetraprotein CD9 in the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) model of newly diagnosed prostate cancer increases spontaneous metastasis in an organ specific manner (i.e., increases liver metastasis rather than lung metastasis) (22).